• 1
    Olivera BM & Cruz LJ (2001) Conotoxin in retrospect. Toxicon 39, 714.
  • 2
    McIntosh JM, Santos AD & Olivera BM (1999) Conus peptides targeted to specific nicotinic acetylcholine receptors subtypes. Annu Rev Biochem 68, 5988.
  • 3
    McIntosh JM, Dowell C, Watkins M, Garrett JE, Yoshikami D & Olivera BM (2002) α-Conotoxin GIC from Conus geographus, a novel peptide antagonist of nicotinic acetylcholine receptors. J Biol Chem 277, 3361033615.
  • 4
    Bai-Song L, Fang Y, Dong Z, Pei-Tang H & Cui-Fen H (1999) Conopeptides from Conus striatus and Conos textile by cDNA cloning. Peptides 20, 11391144.
  • 5
    Becerril B, Marangoni S & Possani LD (1997) Toxins and genes isolated from scorpions of the genus Tityus. Toxicon 35, 821835.
  • 6
    Young Y, Zeni L, Rosenfeld RD, Stark KL, Rohde MF & Haniu M (1999) Disulfide assignment of the C-terminal cysteine knot of agouti-related protein (AGRP) by direct sequencing analysis. J Pept Res 54, 514521.
  • 7
    Bures EJ, Hui JO, Young Y, Chow DT, Katta V, Rohde MF, Zeni L, Rosenfeld RD, Stark KL & Haniu M (1998) Determination of disulfide structure in agouti-related protein (AGRP) by stepwise reduction and alkylation. Biochemistry 37, 1217212177.
  • 8
    Bulaj G, Buczek O, Goodsell I, Jimenez EC, Kranski J, Nielsen JS, Garrett E & Olivera BM (2003) Efficient oxidative folding of conotoxins and the radiation of venomous cone snails. Proc Natl Acad Sci USA 100, 1456214568.
  • 9
    Atherton E & Sheppard RC (1987) The Peptides, pp. 139. Academic Press, New York, NY.
  • 10
    Schnölzer M, Alewood P, Jones A, Alewood D & Kent SBH (1992) In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int J Pept Protein Res 40, 180193.
  • 11
    Luther MA, Schoepfer R, Whiting P, Casey B, Blatt Y, Montal MS, Montal M & Lindstrom J (1989) A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J Neurosci 9, 10821096.
  • 12
    Chaves-Norega LE, Crona JH, Washburn MS, Urrutia A, Elliot KJ & Johnson EC (1997) Pharmacological characterization of recombinant human neuronal acetylcholine hα2β2, hα2β4, hα3β4, hα4β2, hα4β2, hα4β4 and α7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280, 346356.
  • 13
    Zwart R & Vijverberg HP (1998) Four pharmacologically distinct subtypes of α4β2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol Pharmacol 54, 11241131.
  • 14
    Samochoki M, Hoeffle A, Feherenbacher A, Jostock R, Ludwig J, Christner C, Radina M, Zerlin M, Ullmer C, Pereira E et al. (2003) Galantamine is an allosteric potentiating ligand of neuronal nicotinic but not muscarinic acetylcholine receptors. J Pharm Exp Ther 305, 10241036.
  • 15
    Martinez JS, Olivera BM, Gray WR, Craig AG, Groebe DR, Abramson SN & McIntosh JM (1995) α-Conotoxin EI: a new nicotinic acetylcholine receptor antagonist with novel selectivity. Biochemistry 34, 1451914526.
  • 16
    Jakubowski JA & Sweedler JV (2004) Sequencing and mass profiling highly modified conotoxins using global reduction/alkylation followed by mass spectrometry. Anal Chem 76, 65416547.
  • 17
    Terlau H & Olivera BM (2004) Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol Rev 84, 4168.
  • 18
    Nicke A, Loughnan ML, Millard EL, Alewood PF, Adams DJ, Daly NL, Craik DJ & Lewis RJ (2003) Isolation, structure, and activity of GID, a novel α4/7-conotoxin with an extended N-terminal sequence. J Biol Chem 278, 31373144.
  • 19
    Rogers JP, Luginbuhl P, Pemberton K, Harty P, Wemmer DE & Stevens RC (2000) Structure–activity relationships in a peptidic α7 nicotinic acetylcholine receptor antagonist. J Mol Biol 304, 911926.
  • 20
    Hu SH, Loughnan M, Miller R, Weeks CM, Blessing RH, Alewood PF, Lewis RJ & Martin JL (1998) The 1.1 A resolution crystal structure of [Tyr15]EpI, a novel α-conotoxin from Conus episcopatus, solved by direct methods. Biochemistry 37, 1142511433.
  • 21
    McIntosh JM, Hasson A, Spira ME, Gray WR, Li W, Marsh M, Hillyard DR & Olivera BM (1995) A new family of conotoxins that block voltage-gated sodium channels. J Biol Chem 270, 1679616802.
  • 22
    Jacobsen RB, De la Cruz RG, Grose JH, McIntosh JM, Yoshikami D & Olivera BM (1999) Critical residues influence the affinity and selectivity of α-conotoxin MI for nicotinic acetylcholine receptors. Biochemistry 38, 1331013315.
  • 23
    Dutton JL & Craik DJ (2001) α-Conotoxins: nicotinic acetylcholine receptor antagonists as pharmacological tools and potential drug leads. Curr Med Chem 8, 327344.
  • 24
    Janes RW (2005) α-Conotoxins as selective probes for nicotinic acetylcholine receptor subclasses. Curr Opin Pharmacol 5, 280292.
  • 25
    Ellison M, Gao F, Wang H-L, Sine SM, McIntosh JM & Olivera BM (2004) α-Conotoxins ImI and ImII target distinct regions of the human alpha7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes. Biochemistry 43, 1601916026.
  • 26
    Favreau P, Krimm I, Le Gall F, Bobenrieth M-J, Lamthanh H, Bouet F, Servent D, Molgo J, Menez A, Letourneux Y et al. (1999) Biochemical characterization and nuclear magnetic resonance structure of novel α-conotoxins isolated from the venom of Conus consors. Biochemistry 38, 63176326.
  • 27
    Sharpe IA, Gehrmann J, Loughnan ML, Thomas L, Adams DA, Atkins A, Palant E, Craik DJ & Lewis RJ (2001) Two new classes of conopeptides inhibit the α1-adrenoceptor and noradrenaline transporter. Nature Neurosci 4, 902907.
  • 28
    Quick MW & Lester RAJ (2002) Desensitization of neuronal nicotinic receptors. J Neurobiol 53, 457478.
  • 29
    Hogg RC, Raggenbass M & Bertrand D (2003) Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol 147, 146.
  • 30
    Valera S, Ballivet M & Bertrand D (1992) Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 89, 99499953.
  • 31
    Curtis L, Buisson B, Bertrand S & Bertrand D (2002) Potentiation of human α4β2 neuronal nicotinic acetylcholine receptor by estradiol. Mol Pharmacol 61, 127135.
  • 32
    Zwart R & Vijverberg HP (1997) Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects. Mol Pharmacol 52, 886895.
  • 33
    Hsiao B, Dweck D & Luetje C (2001) Subunit-dependent modulation of neuronal nicotinic receptors by zinc. J Neurosci 21, 18481856.
  • 34
    Steibach JH & Chen Q (1995) Antagonist and partial agonist actions of d-tubocurarine at mammalian muscle acetylcholine receptors. J Neurosci 15, 230240.
  • 35
    Hogg RC, Hopping G, Alewood PF, Adams DJ & Bertrand D (2003) α-Conotoxin PnIA and [A10L]PnIA stabilize different states of the α7–L247T nicotinic acetylcholine receptor. J Biol Chem 278, 2690826914.
  • 36
    Sine SM, Kreienkamp HJ, Bren N, Maeda R & Taylor P (1995) Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of determinants of α-conotoxin MI selectivity. Neuron 15, 205211.
  • 37
    De Fusco M, Becchetti A, Patrignani A, Annesi G, Gambardella A, Quattrone A, Ballabio A, Wanke E & Casari G (2000) The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 26, 275276.
  • 38
    Hogg RC & Bertrand D (2007) Partial agonists and therapeutic agents at neuronal nicotinic acetylcholine receptors. Biochem Pharmacol 73, 459468.
  • 39
    Broad LM, Swart R, Pearson HK, Lee M, Wallace L, McPhie G, Emkey R, Hollinshead SP, Dell CP, Baker SR et al. (2006) Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators. J Pharmacol Exp Ther 318, 11081117.
  • 40
    van den Hooven HW, van den Burg HA, Vossen P, Boeren S, de Wit PJGM & Vervoort J (2001) Disulfide bond structure of the AVR9 elicitor of the fungal tomato pathogen Cladosporium fulvum: evidence for a cystine knot. Biochemistry 40, 34583466.
  • 41
    Beuken E, Vink C & Bruggeman CA (1998) One-step procedure for screening recombinant plasmids by size. Biotechniques 24, 748750.
  • 42
    Hancock WS & Battersby JE (1976) A new micro-test for the detection of incomplete coupling reactions in solid-phase peptide synthesis using 2,4,6-trinitrobenzenesulphonic acid. Anal Biochem 71, 260264.
  • 43
    Atherton E & Shepperd RC (1989) Solid Phase Peptide Synthesis: a Practical Approach. IRL Press, Oxford, UK.
  • 44
    Bodansky M (1993) Principles of Peptide Synthesis. Springer-Verlag, Berlin.
  • 45
    Stratton MR, Darling J, Pilkington GJ, Lantos PL, Reeves BR & Cooper CS (1989) Characterization of the human cell line TE671. Carcinogenesis 10, 899905.
  • 46
    Michelmore S, Croskery K, Nozulak J, Hoyer D, Longato R, Weber A, Bouhelal R & Feuerbach D (2002) Study of the calcium dynamics of the human α4β2, α3β4 and α1β1γδ nicotinic acetylcholine receptors. Naunyn Schmiedebergs Arch Pharmacol 366, 235245.
  • 47
    Gurrola GB, Rosati B, Rocchetti M, Pimienta G, Zaza A, Arcangeli A, Olivotto M, Possani LD & Wanke E (1999) A toxin to nervous, cardiac, and endocrine ERG K+ channels isolated from Centruroides noxius scorpion venom. FASEB J 13, 953962.
  • 48
    McIntosh JM, ePlazas PV, Watkins M, Gomez-Casati ME, Olivera BM & Elgoyhen AB (2005) A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors. J Biol Chem 280, 3010730112.